This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hughes, W T Search for Related Content PubMed PubMed Citation Articles by Hughes, W T

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1979 September; 16(3): 333-335

Limited effect of trimethoprim-sulfamethoxazole prophylaxis on Pneumocystis carinii.

W T Hughes

ABSTRACT

Trimethoprim-sulfamethoxazole has been proven effective in the treatment and prevention of Pneumocystis carinii pneumonitis in lower animals and humans. How effective the drug combination is in eradicating P. carinii from the host is not known. The immunosuppressed rat model was used to determine whether or not trimethoprim-sulfamethoxazole effectively eradicated the organism. Animals treated with trimethoprim-sulfamethoxazole for as long as 6 weeks were then placed in individual isolator cages, immunosuppressed with prednisone for 12 weeks, and sacrificed. P. carinii was found in the lungs of at least 90% of the drug-treated as well as untreated control groups. The data indicate that trimethoprim-sulfamethoxazole has a limited rather than a lethal effect on P. carinii and that protection is afforded only during the period of trimethoprim-sulfamethoxazole administration.

---

Antimicrob Agents Chemother. 1979 September; 16(3): 333-335

This article has been cited by other articles:

• Cardenal, R., Medrano, F. J., Varela, J. M., Ordonez, A., Regordan, C., Rincon, M., Martinez, A., Calderon, E. J. (2001). Pneumocystis carinii pneumonia in heart transplant recipients. Eur. J. Cardiothorac. Surg. 20: 799-802 [Abstract] [Full Text]  
• Saah, A. J., Hoover, D. R., Peng, Y., Phair, J. P., Visscher, B., Kingsley, L. A., Schrager, L. K., the Multicenter AIDS Cohort Study, , Saah, A. J., Taylor, E., Margolick, J. B., Markham, R., McArthur, J., Farzadegan, H., Armenian, H., Graham, N., Phair, J. P., Chmiel, J. S., Cohen, B., Wolinsky, S., Detels, R., Visscher, B. R., Fahey, J. L., Giorgi, J. V., Dudley, J., Lee, M., Nishanian, P., Rinaldo, C. R. Jr, Ho, M., Kingsley, L. A., Gupta, P., Winkelstein, A., Mufloz, A., Peng, Y., Galai, N., Hoover, D. R., Nelson, K., Lisa, P. J., Su, S., Schrager, L., Kaslow, R. A., VanRaden, M. J., Seminara, D. (1995). Predictors for Failure of Pneumocystis carinii Pneumonia Prophylaxis. JAMA 273: 1197-1202 [Abstract]  
• Wormser, G. P., Horowitz, H. W., Duncanson, F. P., Forseter, G., Javaly, K., Alampur, S. K., Gilroy, S. A., Lenox, T., Rappaport, A., Nadelman, R. B. (1991). Low-Dose Intermittent Trimethoprim-Sulfamethoxazole for Prevention of Pneumocystis carinii Pneumonia in Patients With Human Immunodeficiency Virus Infection. Arch Intern Med 151: 688-692 [Abstract]  
• WHARTON, J. M., COLEMAN, D. L., WOFSY, C. B., LUCE, J. M., BLUMENFELD, W., HADLEY, W. K., INGRAM-DRAKE, L., VOLBERDING, P. A., HOPEWELL, P. C. (1986). Trimethoprim-Sulfamethoxazole or Pentamidine for Pneumocystis carinii Pneumonia in the Acquired Immunodeficiency Syndrome: A Prospective Randomized Trial. ANN INTERN MED 105: 37-44 [Abstract]  
• Wilber, R. B., Feldman, S., Malone, W. J., Ryan, M., Aur, R. J. A., Hughes, W. T. (1980). Chemoprophylaxis for Pneumocystis carinii Pneumonitis: Outcome of Unstructured Delivery. Arch Pediatr Adolesc Med 134: 643-648 [Abstract]